Showing posts with label (ANGPTL4) via a direct IL6-STAT3-mediated mechanism. Show all posts
Showing posts with label (ANGPTL4) via a direct IL6-STAT3-mediated mechanism. Show all posts

Tuesday, April 28, 2015

New antibody shows promise in increasing survival for patients suffering from influenza, pneumonia



Figure thumbnail fx1



Scientists from NTU Singapore, the world's No. 1 young university, have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia.

Proven effective in lab tests, the antibody is now being made suitable for use in humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.

The patent-pending antibody has generated much interest globally. Two biotech multi-national corporations, Abcam based in the United Kingdom and Adipogen International based in the United States, have won the rights to license the antibody. The two multinational companies will produce the antibody for sale to global organisations doing research in vaccine and drug development.

The breakthrough finding was published in the latest issue of the prestigious international peer-reviewed journal Cell Reports.

Ref : http://www.cell.com/cell-reports/abstract/S2211-1247(15)00024-8